Alex Goldfarb
Stock Analyst at Piper Sandler
(1.89)
# 3,206
Out of 5,152 analysts
20
Total ratings
53.85%
Success rate
1.5%
Average return
Main Sectors:
Stocks Rated by Alex Goldfarb
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CURB Curbline Properties | Maintains: Overweight | $30 → $32 | $28.20 | +13.50% | 3 | Feb 17, 2026 | |
| LINE Lineage | Downgrades: Neutral | $55 → $41 | $39.76 | +3.12% | 5 | Nov 6, 2025 | |
| AVB AvalonBay Communities | Downgrades: Underweight | $189 → $160 | $177.18 | -9.70% | 1 | Nov 7, 2022 | |
| ESS Essex Property Trust | Downgrades: Neutral | $297 → $250 | $254.12 | -1.62% | 1 | Oct 28, 2022 | |
| BXP BXP, Inc. | Downgrades: Neutral | $120 → $100 | $56.17 | +78.03% | 1 | Jul 28, 2022 | |
| EQR Equity Residential | Downgrades: Underweight | $78 → $70 | $62.39 | +12.20% | 1 | Jul 20, 2022 | |
| NMRK Newmark Group | Downgrades: Neutral | $20 → $15 | $15.05 | -0.33% | 2 | Apr 18, 2022 | |
| MAC The Macerich Company | Downgrades: Underweight | $18 → $14 | $19.88 | -29.58% | 5 | Apr 18, 2022 | |
| UDR UDR, Inc. | Downgrades: Underweight | n/a | $37.30 | - | 1 | Jul 27, 2020 |
Curbline Properties
Feb 17, 2026
Maintains: Overweight
Price Target: $30 → $32
Current: $28.20
Upside: +13.50%
Lineage
Nov 6, 2025
Downgrades: Neutral
Price Target: $55 → $41
Current: $39.76
Upside: +3.12%
AvalonBay Communities
Nov 7, 2022
Downgrades: Underweight
Price Target: $189 → $160
Current: $177.18
Upside: -9.70%
Essex Property Trust
Oct 28, 2022
Downgrades: Neutral
Price Target: $297 → $250
Current: $254.12
Upside: -1.62%
BXP, Inc.
Jul 28, 2022
Downgrades: Neutral
Price Target: $120 → $100
Current: $56.17
Upside: +78.03%
Equity Residential
Jul 20, 2022
Downgrades: Underweight
Price Target: $78 → $70
Current: $62.39
Upside: +12.20%
Newmark Group
Apr 18, 2022
Downgrades: Neutral
Price Target: $20 → $15
Current: $15.05
Upside: -0.33%
The Macerich Company
Apr 18, 2022
Downgrades: Underweight
Price Target: $18 → $14
Current: $19.88
Upside: -29.58%
UDR, Inc.
Jul 27, 2020
Downgrades: Underweight
Price Target: n/a
Current: $37.30
Upside: -